US Stock MarketDetailed Quotes

Ocular Therapeutix (OCUL)

Watchlist
  • 10.200
  • -0.340-3.23%
Close Jul 10 16:00 ET
  • 10.390
  • +0.190+1.86%
Post 18:50 ET
2.23BMarket Cap-7.08P/E (TTM)

Ocular Therapeutix (OCUL) Earnings Dates, Reports & Conference Call

OCUL 2026 Q1 Earnings Dates & Summary

Currency:USDMay 5, 2026

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
12.70M
10.79M
-1.92M
Miss Est.
+18.73%
+0.81%
-15.09%
Net Income
-73.15M
-88.61M
-15.46M
Miss Est.
-14.20%
-38.34%
-21.14%
Strong Buy

Jul 12, 2026

OCUL Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q3-- / 14.015M--
--2026/Q2-- / 13.200M--
May 5, 20262026/Q110.785M / 12.701M--
--2025/Q413.250M / 16.142M--
Nov 4, 20252025/Q314.544M / 14.570M--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q3-- / 14.015M--
--2026/Q2-- / 13.200M--
May 5, 20262026/Q110.785M / 12.701M--
--2025/Q413.250M / 16.142M--
Nov 4, 20252025/Q314.544M / 14.570M--

Unlock Free Earnings Estimates

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On July 8, Eastern Time, U.S. forces launched a new round of strikes against Iran aimed at degrading Iran's ability to threaten freedom of n Show More